Nalaganje...

Bevacizumab and intraocular tumors: an intriguing paradox

PURPOSE: Bevacizumab, a humanized monoclonal antibody to vascular endothelial growth factor-A (VEGF-A), was originally developed as an anti-tumor treatment. In ocular oncology, it is being used to treat macular edema due to radiation retinopathy, but it may also be useful for the treatment of primar...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: el Filali, Mariam, Ly, Long V., Luyten, Gregorius P.M., Versluis, Mieke, Grossniklaus, Hans E., van der Velden, Pieter A., Jager, Martine J.
Format: Artigo
Jezik:Inglês
Izdano: Molecular Vision 2012
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3472924/
https://ncbi.nlm.nih.gov/pubmed/23077404
Oznake: Označite
Brez oznak, prvi označite!